ESR1-mutated

Elacestrant: A Breakthrough Drug for Advanced Breast Cancer Gets EU Approval

CHMP Greenlights Elacestrant for Advanced Breast Cancer Treatment in the EU

SG Tylor

Source – Menarini Group A new treatment option for postmenopausal women with advanced or metastatic breast cancer has moved a ...